CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy

被引:0
|
作者
Xiaohui Zhang [1 ]
Liren Wang [1 ]
Mingyao Liu [1 ]
Dali Li [1 ]
机构
[1] Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University
基金
中国国家自然科学基金;
关键词
CRISPR/Cas9; gene therapy; in vivo; ex vivo;
D O I
暂无
中图分类号
R450 [];
学科分类号
100215 ;
摘要
CRISPR/Cas9 is a versatile genome-editing tool which is widely used for modifying the genome of both prokaryotic and eukaryotic organisms for basic research and applications. An increasing number of reports have demonstrated that CRISPR/Cas9-mediated genome editing is a powerful technology for gene therapy. Here, we review the recent advances in CRISPR/Cas9-mediated gene therapy in animal models via different strategies and discuss the challenges as well as future prospects.
引用
收藏
页码:468 / 475
页数:8
相关论文
共 50 条
  • [11] In vivo gene therapy potentials of CRISPR-Cas9
    Xue, H-Y
    Zhang, X.
    Wang, Y.
    Xiaojie, L.
    Dai, W-J
    Xu, Y.
    [J]. GENE THERAPY, 2016, 23 (07) : 557 - 559
  • [12] In vivo gene therapy potentials of CRISPR-Cas9
    H-Y Xue
    X Zhang
    Y Wang
    L Xiaojie
    W-J Dai
    Y Xu
    [J]. Gene Therapy, 2016, 23 : 557 - 559
  • [13] In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
    Maddalo, Danilo
    Manchado, Eusebio
    Concepcion, Carla P.
    Bonetti, Ciro
    Vidigal, Joana A.
    Han, Yoon-Chi
    Ogrodowski, Paul
    Crippa, Alessandra
    Rekhtman, Natasha
    de Stanchina, Elisa
    Lowe, Scott W.
    Ventura, Andrea
    [J]. NATURE, 2014, 516 (7531) : 423 - +
  • [14] AN IN VIVO TRACEABLE AND MULTIPLEXING CRISPR/CAS9 GENOME EDITING SYSTEM
    Cheng, L.
    Niu, T.
    Liu, Y.
    [J]. HAEMATOLOGICA, 2017, 102 : 568 - 568
  • [15] The CRISPR/Cas9 System as a Tool to Engineer Chromosomal Translocation In Vivo
    Cheong, Taek-Chin
    Blasco, Rafael B.
    Chiarle, Roberto
    [J]. CHROMOSOME TRANSLOCATION, 2018, 1044 : 39 - 48
  • [16] In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
    Danilo Maddalo
    Eusebio Manchado
    Carla P. Concepcion
    Ciro Bonetti
    Joana A. Vidigal
    Yoon-Chi Han
    Paul Ogrodowski
    Alessandra Crippa
    Natasha Rekhtman
    Elisa de Stanchina
    Scott W. Lowe
    Andrea Ventura
    [J]. Nature, 2014, 516 : 423 - 427
  • [17] Surveying the Delivery Methods of CRISPR/Cas9 for ex vivo Mammalian Cell Engineering
    Kelton, William J.
    Pesch, Theresa
    Matile, Stefan
    Reddy, Sai T.
    [J]. CHIMIA, 2016, 70 (06) : 439 - 442
  • [18] Therapeutic applications of CRISPR/Cas9 system in gene therapy
    Hasan Mollanoori
    Shahram Teimourian
    [J]. Biotechnology Letters, 2018, 40 : 907 - 914
  • [19] Therapeutic applications of CRISPR/Cas9 system in gene therapy
    Mollanoori, Hasan
    Teimourian, Shahram
    [J]. BIOTECHNOLOGY LETTERS, 2018, 40 (06) : 907 - 914
  • [20] In vivo and in vitro disease modeling with CRISPR/Cas9
    Kato, Tomoko
    Takada, Shuji
    [J]. BRIEFINGS IN FUNCTIONAL GENOMICS, 2017, 16 (01) : 13 - 24